Stocks & Equities

S&P 500 Snapshot: Third Consecutive Daily Loss

Share on Facebook Tweet on Twitter

Posted by Jill Mislinski - Advisor Perspectives

on Friday, 23 June 2017 07:29

The S&P opened Thursday above Wednesday's close and rose for the first couple of hours. It was flat for the remainder of the day until dropping within the last hour. The index ended the day with a loss of 0.05%, its third consecutive daily loss.

A Perspective on Drawdowns

Here's a snapshot of record highs and selloffs since the 2009 trough.


Here is a more conventional log-scale chart with drawdowns highlighted....continue reading HERE

Stocks & Equities

More Fluctuations Along New Record Highs, Will Stocks Continue Higher?

Share on Facebook Tweet on Twitter

Posted by Przemyslaw Radomski - Sunshine Profits

on Thursday, 22 June 2017 06:52

Our intraday outlook is bearish, and our short-term outlook is bearish. Our medium-term outlook remains neutral, following S&P 500 index breakout above last year's all-time high:

Intraday outlook (next 24 hours): bearish
Short-term outlook (next 1-2 weeks): bearish
Medium-term outlook (next 1-3 months): neutral
Long-term outlook (next year): neutral

The U.S. stock market indexes were mixed between -0.3% and +0.7% on Wednesday, as investors continued to hesitate following recent volatility. The S&P 500 index has reached new all-time high at the level of 2,453.82 on Monday following breakout above its short-term consolidation along the level of 2,420-2,440. It is currently trading 0.7% below that new record high. Stocks have rebounded strongly after their mid-May quick two-session sell-off and continued over eight-year-long bull market off 2009 lows. The Dow Jones Industrial Average has reached yet another new all-time high at the level of 21,535.03 on Tuesday. The technology Nasdaq Composite was relatively stronger than the broad stock market yesterday, as it gained 0.7%. However, it continued to trade well below its June 9 high. The nearest important support level of the S&P 500 index is at around 2,430-2,435, marked by Monday's daily gap up of 2,433.15-2,441.79. The next level of support is at 2,415-2,420, marked by some recent local lows. The support level is also at 2,400-2,410, marked by the May 25 daily gap up of 2,405.58-2,408.01, among others. On the other hand, level of resistance is at 2,450-2,455, marked by new all-time high. There have been no confirmed negative signals so far. However, we can see overbought conditions and negative technical divergences. The S&P 500 index is trading within its two-week-long consolidation again, as we can see on the daily chart:


Click Charts For Larger Versions

More Fluctuations?


Stocks & Equities

Small-Cap Mining Stocks, Big-Time Opportunity

Share on Facebook Tweet on Twitter

Posted by Frank Holmes - US Global Investors

on Wednesday, 21 June 2017 07:24


Last month I told you about the upcoming rebalance of the hugely popular VanEck Vectors Junior Gold Miners ETF (GDXJ), and how it would distress shares of junior, small-cap mining stocks. I said then that the rebalance could create some excellent opportunities for astute investors to accumulate high-quality, well-managed producers at discount prices.

That day has finally arrived, bringing with it a tsunami in the junior resource space, as I told Collin Kettell on Palisade Radio the week before. It’s a buyer’s market—if you know what you’re looking for. The last time the GDXJ underwent a rebalance of this magnitude was in December 2014, so I see this as a rare event savvy investors shouldn’t miss out on.

But first a reminder of what’s been happening with the GDXJ. Basically, it had become too massive for its underlying index—composed mostly of Canadian junior gold producers—with assets rising close to $5.5 billion earlier this year, up from $1 billion only last year. 

Mo Money Mo Problems


Stocks & Equities

Legal Pot Is Making This Industry Paranoid about Lost Profits

Share on Facebook Tweet on Twitter

Posted by Bill Hall - Money and Markets

on Friday, 16 June 2017 07:01

In my most recent Money and Markets articles, I’ve put you on the inside track about a rapidly growing, yet mostly still under-the-radar, industry. One that the world’s super-rich are quietly funding with their own money, in pursuit of potentially eye-popping investment returns.

I then told you that industry was the legal cannabis business.

What’s more, I reported that, according to reputable market research, the legal marijuana industry in the U.S. was a $3.4 billion business in 2015. In 2016, this market doubled to $7.1 billion. 

Now, two major studies show that legal marijuana sales will top $40 billion in the U.S. over the next five years. That number could surge to $50 billion over the next decade … or sooner.

Marijuana is legal in more than half of the states in the U.S., for medicinal and even recreational use. With marijuana going mainstream, some of corporate America’s most-profitable and high-profile industries are recognizing the threat marijuana poses to their profits. 

And they are starting to fight back in a big way …


Last week, you learned that the marijuana industry’s biggest enemy is not the Trump administration or U.S. Attorney General Jeff Sessions. 

Rather, it’s the Big Pharma companies like Teva Pharmaceuticals (TEVA)Pfizer (PFE)Johnson & Johnson (JNJ) and Allergan (AGN). Companies with big stakes in the pain-treatment game.

But the legal-pot business faces another formidable foe. 


Stocks & Equities

Stock Cycles

Share on Facebook Tweet on Twitter

Posted by Michael A. Alexander

on Wednesday, 14 June 2017 08:41

44508 a

The Life Expectancy of Economic Expansions


<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >> Page 1 of 323

Free Subscription Service - sign up today!

Exclusive content sent directly to your Inbox

  • What Mike's Reading

    His top research pick

  • Numbers You Should Know

    Weekly astonishing statistics

  • Quote of the Week

    Wisdom from the World

  • Top 5 Articles

    Most Popular postings

Learn more...

Our Premium Service:
The Inside Edge on Making Money

Latest Update

Notes From Michael - June 21st

Posted Wednesday, 21st June 2017  "The State is the great fiction through which everyone endeavours to live at the expense of everyone...

- posted by Michael Campbell

Michael Campbell Robert Zurrer
Tyler Bollhorn Eric Coffin Jack Crooks Patrick Ceresna
Ozzie Jurock Mark Leibovit Greg Weldon Ryan Irvine